GlaxoSmithKline PLC Director/PDMR Shareholding (3318X)

TIDMGSK

RNS Number : 3318X

GlaxoSmithKline PLC

20 February 2017

GlaxoSmithKline plc (the 'Company')

Shares withheld or sold to meet tax liabilities

Following the vesting of the pre-tax awards granted in 2014 under the GlaxoSmithKline Deferred Annual Bonus Plan (DABP) on 16 February 2017 and as notified on 17 February 2017, the notifications that follow reflect changes in the interests of Persons Discharging Managerial Responsibilities (PDMRs) in American Depositary Shares (ADSs) of the Company arising from the withholding of ADSs to meet tax liabilities.

Transaction notification

 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================= 
 a)    Name                       Dr M M Slaoui 
====  ==========================  ============================================= 
 b)    Position/status            Chairman, Global Vaccines 
====  ==========================  ============================================= 
 c)    Initial notification/      Initial notification 
        amendment 
====  ==========================  ============================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================= 
 a)    Name                       GlaxoSmithKline plc 
====  ==========================  ============================================= 
 b)    LEI                        5493000HZTVUYLO1D793 
====  ==========================  ============================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================= 
 a)    Description of             GlaxoSmithKline plc American Depositary 
        the financial              Shares ('ADSs') 
        instrument                 ISIN: US37733W1053 
====  ==========================  ============================================= 
 b)    Nature of the              The withholding of ADSs to meet tax liabilities 
        transaction                further to the vesting of awards granted 
                                   in 2014 under the Company's 2009 Deferred 
                                   Annual Bonus Plan-Deferred Bonus and Matching 
                                   Awards. 
====  ==========================  ================================================= 
 c)    Price(s) and                Price(s)   Volume(s) 
        volume(s)                  ---------  ----------------- 
                                    $40.57     9,237 (Deferred) 
                                   ---------  ----------------- 
                                    $40.57     3,249 (Matching) 
                                   ---------  ----------------- 
====  ==========================  ============================================= 
 d)    Aggregated information 
   Aggregated volume 
    Price 
                                   12,486 
                                    $40.57 
 ===============================  ============================================= 
 e)    Date of the transaction    2017-02-16 
====  ==========================  ============================================= 
 f)    Place of the                n/a 
        transaction 
====  ==========================  ============================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================== 
 a)    Name                      Mr D E Troy 
====  =========================  =============================================== 
 b)    Position/status           SVP & General Counsel 
====  =========================  =============================================== 
 c)    Initial notification/     Initial notification 
        amendment 
====  =========================  =============================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================== 
 a)    Name                      GlaxoSmithKline plc 
====  =========================  =============================================== 
 b)    LEI                       5493000HZTVUYLO1D793 
====  =========================  =============================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================== 
 a)    Description of            GlaxoSmithKline plc American Depositary 
        the financial             Shares ('ADSs') 
        instrument                ISIN: US37733W1053 
====  =========================  =============================================== 
 b)    Nature of the             The withholding of ADSs to meet tax liabilities 
        transaction               further to the vesting of awards granted 
                                  in 2014 under the Company's 2009 Deferred 
                                  Annual Bonus Plan-Deferred Bonus and Matching 
                                  Awards. 
====  =========================  =============================================== 
 c)    Price(s) and               Price(s)   Volume(s) 
        volume(s)                 ---------  ----------------- 
                                   $40.57     3,280 (Deferred) 
                                  ---------  ----------------- 
                                   $40.57     1,208 (Matching) 
                                  ---------  ----------------- 
====  =========================  =============================================== 
 d)    Aggregated information 
   Aggregated volume 
    Price 
                                  4,488 
                                    $40.57 
 ==============================  =============================================== 
 e)    Date of the transaction   2017-02-16 
====  =========================  =============================================== 
 f)    Place of the              n/a 
        transaction 
====  =========================  =============================================== 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHZBLFLDLFBBBK

(END) Dow Jones Newswires

February 20, 2017 09:12 ET (14:12 GMT)